Hayat Pharmaceutical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Hayat Pharmaceutical Industries has a total shareholder equity of JOD29.3M and total debt of JOD1.9M, which brings its debt-to-equity ratio to 6.6%. Its total assets and total liabilities are JOD34.4M and JOD5.1M respectively. Hayat Pharmaceutical Industries's EBIT is JOD2.8M making its interest coverage ratio 28.9. It has cash and short-term investments of JOD7.3M.
Key information
6.6%
Debt to equity ratio
د.أ1.94m
Debt
| Interest coverage ratio | 28.9x |
| Cash | د.أ7.25m |
| Equity | د.أ29.32m |
| Total liabilities | د.أ5.08m |
| Total assets | د.أ34.40m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: HPIC's short term assets (JOD21.2M) exceed its short term liabilities (JOD3.6M).
Long Term Liabilities: HPIC's short term assets (JOD21.2M) exceed its long term liabilities (JOD1.5M).
Debt to Equity History and Analysis
Debt Level: HPIC has more cash than its total debt.
Reducing Debt: HPIC's debt to equity ratio has reduced from 11.8% to 6.6% over the past 5 years.
Debt Coverage: HPIC's debt is well covered by operating cash flow (143.5%).
Interest Coverage: HPIC's interest payments on its debt are well covered by EBIT (28.9x coverage).